Q3 2024 EPS Estimates for Henry Schein, Inc. Reduced by Analyst (NASDAQ:HSIC)

Henry Schein, Inc. (NASDAQ:HSICFree Report) – Analysts at Zacks Research lowered their Q3 2024 earnings per share estimates for Henry Schein in a research report issued to clients and investors on Tuesday, May 28th. Zacks Research analyst U. Biswas now expects that the company will post earnings per share of $1.35 for the quarter, down from their previous estimate of $1.37. The consensus estimate for Henry Schein’s current full-year earnings is $5.09 per share. Zacks Research also issued estimates for Henry Schein’s FY2024 earnings at $5.08 EPS, Q1 2025 earnings at $1.25 EPS, Q2 2025 earnings at $1.33 EPS, Q3 2025 earnings at $1.44 EPS, Q4 2025 earnings at $1.48 EPS, FY2025 earnings at $5.49 EPS and Q1 2026 earnings at $1.41 EPS.

Several other equities research analysts also recently weighed in on HSIC. Barrington Research increased their price target on Henry Schein from $90.00 to $92.00 and gave the stock an “outperform” rating in a report on Wednesday, May 8th. JPMorgan Chase & Co. lifted their target price on shares of Henry Schein from $82.00 to $88.00 and gave the company an “overweight” rating in a report on Wednesday, March 6th. UBS Group cut their price target on shares of Henry Schein from $82.00 to $80.00 and set a “neutral” rating for the company in a report on Wednesday, May 8th. Piper Sandler lifted their price objective on Henry Schein from $78.00 to $86.00 and gave the company an “overweight” rating in a report on Monday, February 26th. Finally, Leerink Partnrs reissued a “market perform” rating on shares of Henry Schein in a research note on Monday, February 26th. One analyst has rated the stock with a sell rating, six have issued a hold rating and five have issued a buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $81.73.

View Our Latest Report on HSIC

Henry Schein Stock Performance

Shares of HSIC opened at $69.34 on Thursday. The company has a current ratio of 1.75, a quick ratio of 1.02 and a debt-to-equity ratio of 0.47. The firm has a market cap of $8.88 billion, a PE ratio of 23.40, a price-to-earnings-growth ratio of 1.76 and a beta of 0.87. Henry Schein has a 12-month low of $60.01 and a 12-month high of $82.63. The company’s 50 day simple moving average is $72.19 and its 200-day simple moving average is $73.17.

Henry Schein (NASDAQ:HSICGet Free Report) last released its quarterly earnings results on Tuesday, May 7th. The company reported $1.10 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.01 by $0.09. The firm had revenue of $3.17 billion for the quarter, compared to the consensus estimate of $3.21 billion. Henry Schein had a return on equity of 13.51% and a net margin of 3.12%. The firm’s quarterly revenue was up 3.7% compared to the same quarter last year. During the same quarter last year, the business posted $1.21 EPS.

Insider Buying and Selling

In other Henry Schein news, CEO Bradford C. Connett sold 6,430 shares of Henry Schein stock in a transaction dated Wednesday, March 20th. The shares were sold at an average price of $74.28, for a total transaction of $477,620.40. Following the completion of the transaction, the chief executive officer now owns 73,108 shares in the company, valued at $5,430,462.24. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In related news, Vice Chairman James P. Breslawski sold 2,907 shares of the stock in a transaction on Monday, March 18th. The stock was sold at an average price of $74.37, for a total transaction of $216,193.59. Following the sale, the insider now owns 209,562 shares of the company’s stock, valued at $15,585,125.94. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, CEO Bradford C. Connett sold 6,430 shares of Henry Schein stock in a transaction dated Wednesday, March 20th. The stock was sold at an average price of $74.28, for a total transaction of $477,620.40. Following the sale, the chief executive officer now owns 73,108 shares of the company’s stock, valued at $5,430,462.24. The disclosure for this sale can be found here. Insiders own 1.14% of the company’s stock.

Institutional Trading of Henry Schein

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Aurora Investment Counsel boosted its holdings in shares of Henry Schein by 0.7% during the third quarter. Aurora Investment Counsel now owns 20,641 shares of the company’s stock worth $1,533,000 after purchasing an additional 140 shares during the last quarter. Arizona State Retirement System grew its holdings in Henry Schein by 0.4% in the 4th quarter. Arizona State Retirement System now owns 35,890 shares of the company’s stock valued at $2,717,000 after buying an additional 149 shares during the period. Empirical Finance LLC increased its stake in shares of Henry Schein by 3.5% during the 1st quarter. Empirical Finance LLC now owns 4,764 shares of the company’s stock valued at $360,000 after acquiring an additional 160 shares during the last quarter. Covestor Ltd lifted its holdings in shares of Henry Schein by 12.8% during the 1st quarter. Covestor Ltd now owns 1,511 shares of the company’s stock worth $114,000 after acquiring an additional 171 shares during the period. Finally, Keene & Associates Inc. boosted its position in shares of Henry Schein by 4.0% in the first quarter. Keene & Associates Inc. now owns 4,505 shares of the company’s stock worth $340,000 after acquiring an additional 175 shares during the last quarter. 96.62% of the stock is owned by hedge funds and other institutional investors.

About Henry Schein

(Get Free Report)

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Further Reading

Earnings History and Estimates for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.